Koszty Sprzedaży I Administracji Zmiana Data
Agios Pharmaceuticals USD 51.55M 13.09M 2026-06
Alnylam Pharmaceuticals USD 342M 5.92M 2026-09
Anika Therapeutics USD 10.01M 14K 2025-12
Arrowhead Research USD 46.63M 4.88M 2026-06
Heron Therapeutics USD 23.74M 605K 2025-12
Incyte USD 364.27M 12.54M 2026-09
Ionis Pharmaceuticals USD 154M 23.92M 2026-09
Ligand Pharmaceuticals USD 72.62M 43.49M 2026-09
Merck USD 2.86B 25M 2026-09
Moderna USD 282M 66M 2026-09
Nektar Therapeutics USD 11.87M 1.7M 2026-03
Novartis USD 3.08B 163M 2026-09
Sarepta Therapeutics USD 118.61M 11.01M 2026-09
TG Therapeutics USD 88.22M 25.89M 2026-09
Ultragenyx Pharmaceutical USD 97M 9M 2026-09
Vertex Pharmaceuticals USD 556.3M 25.9M 2026-09
Xencor USD 71.93M 5.61M 2026-09